Look back at pharma news in week to March 8

tpl-week-in-review-700x466

By Barbara Obstoj-Cardwell. Editor

The flurry of pharma/biotech M&A deals since the start of 2019 continues into March, with Biogen announcing its $877 million deal to acquire Nightstar Therapeutics. The decision last week of US Food and Drug Administration Commissioner Scott Gottlieb – seen as one of the most proactive heads of the FDA - to quit the post after just two years came as something of a surprise. Significant regulatory news last week included FDA approval for Johnson & Johnson subsidiary Janssen’s ketamine-based antidepressant Spravato. On the research front, Allergan’s hopes for its depression candidate rapastinel suffered a setback in the latest trial data revealed on Wednesday.

Nightstar gives Biogen a cheap way to expand in gene therapy

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Company News Directory

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical